These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29463886)
61. Acoustical analysis of vowel duration in apraxia of speech: a case study. Caligiuri MP; Till JA Folia Phoniatr (Basel); 1983; 35(5):226-34. PubMed ID: 6654272 [No Abstract] [Full Text] [Related]
62. moz regulates Hox expression and pharyngeal segmental identity in zebrafish. Miller CT; Maves L; Kimmel CB Development; 2004 May; 131(10):2443-61. PubMed ID: 15128673 [TBL] [Abstract][Full Text] [Related]
63. Neurogenomics of speech and language disorders: the road ahead. Deriziotis P; Fisher SE Genome Biol; 2013 Apr; 14(4):204. PubMed ID: 23597266 [TBL] [Abstract][Full Text] [Related]
64. Singh M; Spendlove S; Wei A; Bondhus L; Nava A; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA bioRxiv; 2023 Aug; ():. PubMed ID: 37577627 [TBL] [Abstract][Full Text] [Related]
65. Genetic insights into the functional elements of language. Szalontai A; Csiszar K Hum Genet; 2013 Sep; 132(9):959-86. PubMed ID: 23749164 [TBL] [Abstract][Full Text] [Related]
66. Speech, language and communication phenotyping in rare genetic syndromes: Commentary on Speech and language deficits are central to SETBP1 haploinsufficiency disorder. Freeth M; Al-Jawahiri R; Smith H; Stokes L Eur J Hum Genet; 2021 Aug; 29(8):1166-1167. PubMed ID: 34413496 [No Abstract] [Full Text] [Related]
67. Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development. Antonyan L; Ernst C Front Neurosci; 2022; 16():813430. PubMed ID: 35685777 [TBL] [Abstract][Full Text] [Related]
68. Correction: Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development. Kaspi A; Hildebrand MS; Jackson VE; Braden R; van Reyk O; Howell T; Debono S; Lauretta M; Morison L; Coleman MJ; Webster R; Coman D; Goel H; Wallis M; Dabscheck G; Downie L; Baker EK; Parry-Fielder B; Ballard K; Harrold E; Ziegenfusz S; Bennett MF; Robertson E; Wang L; Boys A; Fisher SE; Amor DJ; Scheffer IE; Bahlo M; Morgan AT Mol Psychiatry; 2023 Apr; 28(4):1664-1666. PubMed ID: 36658335 [No Abstract] [Full Text] [Related]
69. Mapping of Human Becker M; Devanna P; Fisher SE; Vernes SC Front Mol Neurosci; 2018; 11():47. PubMed ID: 29515369 [TBL] [Abstract][Full Text] [Related]
70. Schinzel-Giedion syndrome: a novel case, review and revised diagnostic criteria. Liu WL; He ZX; Li F; Ai R; Ma HW J Genet; 2018 Mar; 97(1):35-46. PubMed ID: 29666323 [TBL] [Abstract][Full Text] [Related]
71. Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation. Hildebrand MS; Jackson VE; Scerri TS; Van Reyk O; Coleman M; Braden RO; Turner S; Rigbye KA; Boys A; Barton S; Webster R; Fahey M; Saunders K; Parry-Fielder B; Paxton G; Hayman M; Coman D; Goel H; Baxter A; Ma A; Davis N; Reilly S; Delatycki M; Liégeois FJ; Connelly A; Gecz J; Fisher SE; Amor DJ; Scheffer IE; Bahlo M; Morgan AT Neurology; 2020 May; 94(20):e2148-e2167. PubMed ID: 32345733 [TBL] [Abstract][Full Text] [Related]
72. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Snijders Blok L; Rousseau J; Twist J; Ehresmann S; Takaku M; Venselaar H; Rodan LH; Nowak CB; Douglas J; Swoboda KJ; Steeves MA; Sahai I; Stumpel CTRM; Stegmann APA; Wheeler P; Willing M; Fiala E; Kochhar A; Gibson WT; Cohen ASA; Agbahovbe R; Innes AM; Au PYB; Rankin J; Anderson IJ; Skinner SA; Louie RJ; Warren HE; Afenjar A; Keren B; Nava C; Buratti J; Isapof A; Rodriguez D; Lewandowski R; Propst J; van Essen T; Choi M; Lee S; Chae JH; Price S; Schnur RE; Douglas G; Wentzensen IM; Zweier C; Reis A; Bialer MG; Moore C; Koopmans M; Brilstra EH; Monroe GR; van Gassen KLI; van Binsbergen E; Newbury-Ecob R; Bownass L; Bader I; Mayr JA; Wortmann SB; Jakielski KJ; Strand EA; Kloth K; Bierhals T; ; Roberts JD; Petrovich RM; Machida S; Kurumizaka H; Lelieveld S; Pfundt R; Jansen S; Deriziotis P; Faivre L; Thevenon J; Assoum M; Shriberg L; Kleefstra T; Brunner HG; Wade PA; Fisher SE; Campeau PM Nat Commun; 2018 Nov; 9(1):4619. PubMed ID: 30397230 [TBL] [Abstract][Full Text] [Related]
74. IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease. Morales-Briceño H; Cruse B; Fois AF; Lin MW; Jiang J; Banerjee D; Grunstein R; Varikatt W; Rodriguez M; Shepherd C; Fung VSC Neurology; 2018 Jun; 90(24):1113-1115. PubMed ID: 29769372 [No Abstract] [Full Text] [Related]
75. A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers. Roohullah A; Cooper A; Lomax AJ; Aung J; Barge A; Chow L; McHale M; Desai J; Whittle JR; Tran B; de Souza P; Horvath LG Invest New Drugs; 2018 Oct; 36(5):886-894. PubMed ID: 29766337 [TBL] [Abstract][Full Text] [Related]
77. Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants. Gray B; Hasdemir C; Ingles J; Aiba T; Makita N; Probst V; Wilde AAM; Newbury-Ecob R; Sheppard MN; Semsarian C; Sy RW; Behr ER Heart Rhythm; 2018 Jul; 15(7):1051-1057. PubMed ID: 29758173 [TBL] [Abstract][Full Text] [Related]
78. Underdiagnosis and Overdiagnosis of Asthma. Aaron SD; Boulet LP; Reddel HK; Gershon AS Am J Respir Crit Care Med; 2018 Oct; 198(8):1012-1020. PubMed ID: 29756989 [TBL] [Abstract][Full Text] [Related]
79. Delays to diagnosis and treatment of lung cancer in Australia: healthcare professional perceptions of actual versus acceptable timeframes. Malalasekera A; Dhillon HM; Blinman PL; Kao SC; Vardy JL Intern Med J; 2018 Sep; 48(9):1063-1071. PubMed ID: 29756277 [TBL] [Abstract][Full Text] [Related]